Farmakologiczne aspekty hydrazydów i pochodnych związków hydrazydowych

Autor

  • Musa T. Abidov Instytut Immunopatologii i Medycyny Zapobiegawczej w Lublanie, Słowenia

DOI:

https://doi.org/10.5604/01.3001.0010.7718

Słowa kluczowe:

hydrazydy, hydrazonowe- hydrazydy, izoniazyd, phthalhydrazides, tamerit, galavit

Abstrakt

Intensywne poszukiwania nowych leków przeciwbakteryjnych, łącznie ze środkami przeciwguźliczymi, dyktowane są występowaniem zjawiska wielolekowej oporności bakteryjnej. Hydrazydy uważane są za kluczowe intermediaty i wartościowy początkowy materiał d la nowych biologicznie aktywnych związków chemicznych. Ocenę biologicznych właściwości przeciwbakteryjnych lub/i przeciwgrzybiczych wykonuje się dla ponad 70% ostatnio zaprezentowanych syntetycznych pochodnych hydrazydowych. Najpowszechniej stosowanym hydrazydem jest przeciwgruźliczy lek izoniazyd/ hydrazyd kwasu izonikotynowego (NIH). Hydrazydowe związki chemiczne posiadają charakterystyczną wspólną grupę funkcjonalną, w której występuje wiązanie kowalencyjne azot-azot, z czterema podstawnikami, z których przynajmniej jeden stanowi acyl, z kolei pochodne związki hydrazynowe nie posiadają grupy acylowej. Hydrazydy mogą być dalej sklasyfikowane na podstawie rodzaju pierwiastków przyłączonych do tlenu: karbohydrazydy, sulfonohydrazydy, fosfodihydrazydy, hydrazydy hydrazonowe oraz hydrazydy ftalowe. Poza właściwościami przeciwbakteryjnymi i przeciwgrzybicznymi, pochodne związki hydrazydowe stały się ostatnio interesujące z uwagi na ich właściwości przeciwzapalne. Ftalowa pochodna hydrazydowa tamerit/galavit została pomyślnie wprowadzona do terapii u ludzi.

Pobrania

Statystyki pobrań niedostępne.

Bibliografia

Kumar N., Chachan L.S. Antimicrobial potential of hydrazide-hydrazonederivatives: A review. Int J Pharmaceut Clin Res, 2015, 7, 154-161.

Kumari M., Narang R. Structure activity relationship and mechanism of action of hydrazide derivativesas antimicrobial molecule. J Chem Pharmaceut Res, 2016, 8, 823-836.

Rollas S., Küçükgüzel S.G. Biological activities of hydrazone derivatives. Molecules, 2007, 12, 1910-1939.

Kumar P., Narasimhan B. Hydrazides/hydrazones as antimicrobialand anticancer agents in the new millennium. Mini Rev Med Chem, 2013, 13, 971-987.

Narang R., Narasimhan B. et al. A review on biological activities and chemical synthesis of hydrazide derivatives. Curr Med Chem, 2012, 19, 569-612.

Figueiredo J.M., Camara C.A. et al. Design and synthesis of novel potentantinociceptive agents: methyl-imidazolylN-acylhydrazone derivatives. Bioorg Med Chem, 2000, 8, 2243-2248.

Reddy K.K., Rao S., Rao B.S. Synthesisand characterization and biological activities of hydrazones. Int J Innovat Res Sci Engineer Technol, 2015, 4, 1844-1850.

Singh N., Ranjana R., Kumari M. et al. A review on biological activities of hydrazowe derivatives. Int J Pharmaceut Clin Res, 2016, 8, 162-166.

Gujan J., Awadh D. Synthesis and biological evaluation of some phenylacetic acid hydrazone derivatives. Int Res J Pharm, 2011, 2, 110-112.

Abidov M.T., ed. Hapravlennaia immunokorrekcia: Problemy, perspektivy. [Directive immunocorrection: Problems and perspectives] Izdatielstvo RAMN, Moscow, 2000.

Nagoev B.C., Abidov M.T., Ponezeva Z.B. Chroniczeskije virusnyje giepatity:immunopatologiczeskije, kliniko-diagnosticzeskije i terapeuticzeskije aspekty (Russian) [Chronicviral hepatitis: immunopathogenetic,clinical-diagnostic and therapeuticaspects] 2005. Guripp Adigea, Maikop.

Hazari P.P., Chuttani N., Mathur R.,Sharma R. Synthesis and biological evaluation of isonicotinic acidhydrazide conjugated with diethylenetriaminepentaaceticacid for infectionimaging. Open Nucl Med J, 2009, 1, 33-42.

Toliwal S., Jadav K., Patel K. Synthesis and biological evaluation of fattyhydrazides of by-products of oil processing industry. Indian J Pharmaceut Sci, 2009 (March-April), 144-148.

Mohared R.M., El Sharkawy K.A.,Hussein M.M. et al. Synthesis of hydrazide-hydrazone derivatives and their evaluation of antidepressant, sedative and analgesic agents. J Pharm Sci Res, 2010, 2, 185-196.

Quement S.T., Flagstad T., Mikkelsen R.J. et al. Petasis three-component coupling reactions of hydrazides for the synthesis of oxadiazolones and oxazolidinones. Org Lett, 2011, 20, 1-2.

Kostecka M. Synthesis of a new group of aliphatic hydrazide derivatives and the correlations between their molecular structure and biological activity. Molecules, 2012, 17, 3560-3573.

Bonacorso H.G., Paim, G.R., Porte L.M., Pittaluga E.P. et al. 6-Hydrazononicotinicacid hydrazide: a useful precursor for chemo- and regioselective synthesis of new heteroaryl-linked pridinohydrazaones. ARKIVOC, 2012, 8, 214-225.

Bamanie F.H., Shehata A.S., Moustafa M.A., Mashaly M.M. Enaminones in heterocyclic syntheses: part 5: izoniazid-enaminone a new organic synthon and tuberculostatic candicate. Nat Sci, 2012, 10, 7-10.

Wardakhan W.W., El-Sayed N.N., Mohareb R.M. Synthesis and anti-tumor evaluation of novel hydrazide and hydrazide-hydrazonederivatives. Acta Pharm, 2013, 63,45-57.

Ivanovic I., Gligorijevic N., Arandelovic S. et al. New Ruthenium (II)-arene complexes bearing hydrazides and the corresponding (thio) semicarbazones of 3- and 4-acetylpyridine: Synthesis, characterization, crystal structure determination and antiproliferative activity. Polyhedron, 2013, 61, 112-118.

Siddique M., Saeed A.B., Shahzad S.A. et al. Synthesis and biological evaluation of hydrazide based formamidesderivatives. J Sci Innovat Res, 2013, 2, 772-776.

Poggi M., Barosso R., Costa-Filho A. et al. New isoniazid complexes, promising agents against Mycobacterium tuberculosis. J Mex Chem Soc, 2013, 57, 198-204.

Reddy M., Reddy D., Prasad A.R. et al., Synthesis, characterization and antimicrobial activity of certain novelaryl hydrazone pyrazoline-5-onescontaining thiazole moiety. Adv Pharm Bull, 2013, 3, 153-159.

El-Hashash M.A., Guirguis D.B., El-Wahed N.A. et al. Synthesis of novel series of phthalazine derivatives with antibacterial and antifungal evaluation. Chem Eng Proc Technol, 2014, 5, 1-6.

Roman L., Chundak S. Synthesis, structure and characteristics of Zn(II) and Cd(II) coordination comcompounds with 3-methoxybenzene acid hydrazide and their biological activity. Chem Chemical Technol, 2014, 2, 123-128.

Bhat M., Belagali S.L., Murali M. et al. Synthesis, characterization and biological activities of hydrazide Schiff’s bases. IJCPS, 2014, 3, 82-90.

Reddy K.K., Rao S., Rao B.S. Synthesis and characterization and biological activities of hydrazones, 2015, 4, 18944-19850.

Backes G.L., Neumann D.M., Jurisic B.S. Synthesis and antifungal activity of substituted salicyl aldehydehydrazones, hydrazides and sulfohydrazides. J Bioorg Med Chem, 2014, 22, 4629-4636.

Gupta M., Kumar S., Gupta M.K. Synthesis and antimicrobial activity of some novel derivatives of 7-hydroxy-4-methyl coumarin. Int J Pharmaceut Sci, 2015, 1, 19-26.

Salman A.S., Mahmoud N.A., Abdel-Aziem A. et al. Syntheis, reactions and antimicrobial activity of some new 3-substituted indole derivatives. Int J Org Chem, 2015, 5, 81-99.

Kumar S., Narang R., Kumar Nayak S. et al. Synthesis, antimicrobial evaluation and QSAR studies ofN’-benzylidiene/ (1-phenylethylidiene) undec-10-enehydrazides. J Appl Pharm Sci, 2016, 6, 104-116.

Sangani C.B., Makwana J.A., et al. Synthesis of 1H-pyrazolo [1,2-b] phthalazine-5,10-dione derivatives: assessment of their antimicrobial, antituberculosis and antioxidant activity. Res Chem Intermed, 2016, 42, 2101-2117.

Rollas S., Küçükgüzel S.G. Biological activities of hydrazone derivatives. Molecules, 2007, 12, 1910-1939.

Kumar P., Narasimhan B. Hydrazides/hydrazones as antimicrobial and anticancer agents in the new millennium. Mini Rev Med Chem, 2013, 13, 971-987.

Narang R., Narasimhan B. et al. A review on biological activities and chemical synthesis of hydrazide derivatives. Curr Med Chem, 2012, 19, 569-612.

Figueiredo J.M., Camara C.A. et al. Design and synthesis of novel potentantinociceptive agents: methyl-imidazolylN-acylhydrazone derivatives Bioorg Med Chem, 2000, 8, 2243-2248.

Koopaei M.N., Assarzadeh J. et al. Synthesis and analgesic activity of novel hydrazide and hydrazine derivatives. Iranian J Pharm Res, 2013, 12, 721-727.

Cordeiro N.M., Freitas R.H., Fraga C.A. et al. Discovery of novel orallyactive tetrahydro-naphthyl-N-acylhydrazoneswith in vivo anti-TNF-αeffect and remarkable anti-inflammatoryproperties. PLOS One, 2016, 10, 1-17.

Ghahremandzadeh R., Ahadi S. et al. Reaction of phtahlhydrazide and acetylendedicarboxylates in the presence of N-heterocycles: an efficient synthesis of phthalhydrazidederivatives. Tetrahydron Lett, 2008, 49, 4479-4482.

Gupta P., Gupta J.K. et al. Synthesisand biological significance of pyrazolonens: A review. Int J Pharm Sci Res, 2015, 6, 2291-2310.

Sangani C.B., Makwana J.A. et al. Synthesis of 1H-pyrazolo [1,2-b] phthalazine-5,10-dione derivatives: assessment of their antimicrobial, antituberculosis and antioxidant activity. Res Chem Intermed, 2016, 42, 2101-2117.

Timmins G.S., Deretic V. Mechanisms of action of isoniazid. Mol Microbiol, 2006, 62, 1220-1227.

Getahun H., Granich R., Sculier D. et al. Implementation of isoniazid preventive therapy for people living with HIV worldwide: barriers andsolutions. AIDS, 2010, 24(5), 57-65.

Kozminykh V.O. Synthesis and biological activity of substituted amidesand hydrazides of 1,4-dicarboxylicacids (A review). Pharm Chem J, 2006, 40, 8-15.

Saukkonen J.J., Cohn D.L., Jasmer R.M. et al. An official ATS statement: Hepatotoxicity of antituberculosis therapy. Am J Respir Crit Care Med, 2006, 174, 935-952.

Zeiger E., Anderson B., Haworth S., Lawlor T., Mortelmans K. Salmonellamutagenicity tests: V. Results from the testing of 311 chemicals. Environ Mol Mutagen, 1992, 19, 2-141.

Dao T.V., Casas A.I., Maghzal G.J. et al. Pharmacology and clinical drugcandidates in redox medicine. Antiox Redox Signal, 2015, 23, 1113-1125.

Narang R., Sharma S., Narasimhan B. Evaluation of anti-inflammatory activity of acid hydrazide derivatives. Hygeia J Drug Med, 2012, 4, 15-20.

Shekharchi M., Navidpour L., Khorami A.R. et al. Synthesis of N-aryldiene-2-(-2-phenoxyphenyl) acetohydrazidesas anti-inflammatory agents. Iranian J Pharmacol Res, 2011, 10, 369-377.

Melo T.R., Cheluci R.C., Pires M.L. et al. Pharmacological evaluation and preparation of nonsteroidal ananti-inflammatory drugs containing N-acyl hydrazone derivative. Int J Mol Sci, 2014, 15, 5821-5837.

Lacerda R.B., Sales N.M., Silva L.L. et al. Novel potent inidazo [1,2-a] pyridine-N-glicinyl- hydrazone inhibitors of TNF-α production: in vitro and in vivo studies. PLOS ONE, 2014, 9, e91660.

Patel U., Rajasingh S., Samanta S. et al. Macrophage polarization in response to epigenetic modifiers during infection and inflammation. Drug Discov Today, 2016, 22, 186-193.

Shao J., Li Y., Wang Z., Xiao M et al. 7b, a novel naphthalimide derivative, exhibited anti-inflammatoryeffects via targeted-inhibiting TAK1following down-regulation ERK1/2-and p38 MAPK-mediated activation of NF-κB in LPS stimulated RAW264.7 macrophages. Int Immunopharmacol, 2013, 17, 216-228.

Schultze J.L. Reprogramming macrophages – new opportunities for therapeutic targeting. Curr Opin Pharmacol, 2016, 26, 10-15.

Opublikowane

2017-06-30

Jak cytować

Abidov, M. (2017). Farmakologiczne aspekty hydrazydów i pochodnych związków hydrazydowych. Health Promotion & Physical Activity, 2(3), 9-24. https://doi.org/10.5604/01.3001.0010.7718

Inne teksty tego samego autora